A new COVID variant is raising questions and capturing the attention of researchers heading into the fall and winter season. It's called the XEC variant.

That means like other variations of COVID, the symptoms are similar: The new vaccines are monovalent, or target one variant. This shot targets the KP.2, but since XEC has similarities between KP.2 and XEC, experts believe that the vaccine should work.